Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AstraZeneca Seeks Cmte. Input On Further Iressa Marketing Steps

Mar 02 2005

• By Andrew Kasper

Related Content

“Drug Watch” Website Included In FDA’s Rx Safety Reforms

Feb 15 2005

Iressa Advisory Committee Will Not Vote On Oncologic’s Status – AstraZeneca

Feb 01 2005

Fate Of AstraZeneca's Iressa To Be Discussed By Advisory Cmte. March 4

Jan 31 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window